Comparative Analysis of Cytological and Histopathological Diagnostic Tests in Bronchopulmonary Cancer

A comparative analysis of cytological and histopathological diagnostic tests in bronchopulmonary cancer was thus undertaken, based on 6 years of cases at hospital level. Samples collected from 150 patients were under analysis, with 4 samples being eventually excluded. In the remaining 146 patients, the biological material was evaluated both from a cytological and histopathological standpoint, 67.12% of patients being male, 69.17% being aged between 51 and 70 and 67.12% coming from an urban environment. 68 samples were proved to be malignant (46.57%) in a cytological exam and 82 (56.15%) in a histopathological exam. The histopathological exam also presented the following types of tumors: NSCLC squamous carcinoma (64.63%), NSCLCadenocarcinoma (29.27%), SCLC carcinoma (3.66%) and NSCLC-“NOS” carcinoma (2.44%). Cytology has a sensitivity of 87.80%, specificity of 96.87%, positive predictive value of 97.29% and negative predictive value of 86.11%. The accuracy of a cytological examination compared to a histopathological one is of 91.78% while diagnostic concordance values are at 85.33%. The cytological testing is relatively safe, more accessible, less costly and faster, allowing for a quick